Ranbaxy Laboratories fell 0.82% to Rs 701.10 at 15:20 IST on BSE after the company reported consolidated net loss of Rs 1029.72 crore in Q3 December 2014, higher than net loss of Rs 158.94 crore in Q3 December 2013. The Q3 result was announced ... Capital Market, 3 days ago
Pharmaceutical Newsletter - January 27 to 30, 2015 - India Infoline, 1 day ago
Ranbaxy third quarter consolidated loss widens to Rs 1,030 crore - Economic Times, 2 days ago
1 images for "ranbaxy lab"
Ranbaxy Laboratories is currently trading at Rs. 620.00, up by 4.55 points or 0.74% from its previous closing of Rs. 615.45 on the BSE. The scrip opened at Rs. 611.10 and has touched a high and low of Rs. 621.75 and Rs. 611.10 respectively. So far ...Arihant Capital, 2 months ago Ranbaxy Laboratories : Labs to take its novel drug Synriam to Africa 4 Traders, 1 month ago Approval for Ranbaxy to launch Synriam in 7 African nations Moneycontrol.com, 1 month ago Ranbaxy gets nod to launch Synriam in 7 African countries Moneycontrol.com, 1 month ago
Ranbaxy Laboratories rose 3.69% to Rs 635 at 12:21 IST on BSE after the company said it has launched Infimab, the first Remicade (Infliximab) biosimilar in India. The announcement was made during market hours today, 1 December 2014. ...Capital Market, 2 months ago Fortis HealthWorld Acquires Pharma Retail Chain CRS Health VC Circle, 1 month ago Ranbaxy Labs launches arthritis drug Infimab in India Business Today India, 2 months ago Ranbaxy launches Indias first biosimilar of Infliximab drug, Infimab Moneycontrol.com, 2 months ago
India,United States : CCI grants approval for SUN PHARMA and RANBAXY LABS merger [TendersInfo (India)]
The Competition Commission of India (CCI) has granted approval for the proposed merger between the Sun Pharma and Ranbaxy Labs. The merger will result in a combined entity with annual sales worth $4.3 billion, making it the fifth-largest generic ...Pharmacy Choice, 1 month ago Sun Pharma gains after CCI approves merger with Ranbaxy Lab Business Standard, 1 month ago Sun Pharma and Ranbaxy Lab will be in focus after CCI approves merger Capital Market, 1 month ago CCI clears Sun Pharma's deal to buy Ranbaxy Labs The Gulf Today, 1 month ago
Mumbai, Dec 9 (PTI) Shares of Ranbaxy Lab and Sun Pharma today gained as much as 4 per cent after the drug-makers got fair trade watchdog CCI's approval for their long-pending USD 4-billion merger, though with riders. Ranbaxy Lab's stock rose 4 per ...Press Trust of India, 1 month ago Ranbaxy Lab, Sun Pharma gain up to 3.5 per cent as CCI clears deal Economic Times, 1 month ago Ranbaxy, Sun Pharma gain up to 3.5% as CCI clears deal Economic Times, 1 month ago Ranbaxy, Sun Pharma gain as CCI clears deal Rediff.com, 1 month ago
Last month, FDA told Ranbaxy that it believed its decisions to grant the company tentative approvals for copies of Nexium and Roche AG's antiviral Valcyte were "in error". Ranbaxy Laboratories Ltd has sued thUS Food and Drug Administration (FDA) for revoking ...India Infoline, 2 months ago Ranbaxy Labs sues FDA Reuters India, 2 months ago Ranbaxy sues FDA for revoking approvals for Nexium, Valcyte Moneycontrol.com, 2 months ago Ranbaxy sues FDA for revoking nods to 2 generic drugs The Financial Chronicle, 2 months ago
According to Satish Gupta of astrostocktips, pharma stocks like Divis Labs, Glenmark Pharma, Ipca Lab and Ranbaxy Labs will get astro support.Money Control, 1 month ago
Ranbaxy Laboratories declined 2.03% to Rs 629.10 at 15:25 IST on BSE on reports company has sued the US Food and Drug Administration for revoking approvals granted to the firm to launch copies of two drugs. Meanwhile, the S&P BSE Sensex was down 24.44 points ...Business Standard, 2 months ago
Brokerage house Motilal Oswal is bullish on Ranbaxy Laboratories and has recommended buy rating on the stock with a target price of Rs 800, in its research report dated January 28, 2015.Money Control, 1 day ago Accumulate Ranbaxy Labs; target of Rs 670: KRChoksey Money Control, 2 months ago
Bharti Airtel | Tata Motors | Idea Cellular | Yes Bank | GMR Infrastructure | Amara Raja Batteries | Titan Company | Sadbhav Engineering | Gammon Infrastructure | Larsen and Toubro | Ranbaxy Labs | Hindalco Industries | GE Shipping | Cholamandalam Investment ...Money Control, 3 days ago Stocks in news: TVS Motor, SBI, Ranbaxy, Hindalco, Maruti Money Control, 4 days ago Stocks in news: Ranbaxy, Maruti, JP Associates, IOC, KEC Money Control, 1 month ago Stocks in news: Infosys, Ranbaxy, LT, Bharti, Fin Tech Money Control, 2 months ago
on your WebpageAdd Widget >Get your members hooked!